secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001193125-25-004427
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Olema exchanges ~6.07M shares for pre-funded warrants with Bain, Paradigm, BVF
------------------------------------------------------------------------------

- Entered exchange agreements to swap 6,070,000 common shares for pre-funded warrants at $0.0001 exercise price.
- Exchange expected to close Jan 13, 2025; post-close outstanding shares estimated at 68,333,065.
- Warrants exercisable immediately; beneficial ownership capped at 9.99% (can be raised to 19.99% with notice).
- Issuance exempt from registration under Securities Act Section 3(a)(9); not a registered offering.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000119312525004427/0001193125-25-004427-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000119312525004427/d915597d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-004427

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer